Orchid Pharma Ltd.
NSE: ORCHPHARMA | BSE: 524372
₹708.65
₹-11.40
(-1.58%)
As on 12-May-2026IST
Market cap
₹3,590 Cr
Revenue (TTM)
₹811 Cr
P/E Ratio
190.3
P/B Ratio
2.8
Div. Yield
0 %
Quality Score
2/10
Growth Score
5/10
Valuation Score
3/10
Momentum Score
3/10
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹19 Cr
-
ROE
7.9 %
-
ROCE
8 %
-
Industry P/E
40.13
-
EV/EBITDA
50.3
-
Debt to Equity
0.1
-
Book Value
₹248.8
-
EPS
₹5.2
-
Face value
10
-
Shares outstanding
50,719,105
10 Years Aggregate
CFO
₹910.82 Cr
EBITDA
₹711.52 Cr
Net Profit
₹-1,028.73 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Orchid Pharma
| -6.6 | 26.8 | 2.7 | -8.7 | 19.5 | -14.1 | 33.3 |
|
BSE Healthcare
| 6.1 | 8.1 | 6.7 | 11.8 | 25.8 | 13.4 | 11.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
|---|---|---|---|---|---|
|
Orchid Pharma
| -58.7 | 147.8 | 95.7 | -7.8 | 205.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Orchid Pharma
|
708.7 | 3,589.9 | 811.2 | 17.4 | 0.8 | 2.1 | 190.3 | 2.8 |
| 1,098.8 | 13,485.7 | 2,512.3 | 543.7 | 28.3 | 19.3 | 24.8 | 4.3 | |
| 444.8 | 7,723.6 | 1,053.1 | 293.6 | 32.3 | 24.6 | 26.3 | 6.0 | |
| 1,127.2 | 11,795.0 | 1,158.7 | 309.6 | 31.9 | 17.3 | 37.7 | 6.2 | |
| 1,657.5 | 31,413.1 | 9,203.5 | 941.3 | 15.4 | 19.6 | 34 | 6.3 | |
| 362.3 | 3,946.2 | 159.3 | 47.8 | 39.0 | 18.6 | 82.6 | 14.3 | |
| 17,003.0 | 21,811.5 | 2,023.0 | 364.0 | 23.9 | 20.8 | 121.8 | 13.1 | |
| 2,311.1 | 3,828.0 | 707.5 | 115.2 | 17.8 | 19.4 | 33.2 | -- | |
| 932.9 | 4,281.6 | 588.5 | 102.9 | 22.1 | 12.7 | 42.1 | 5.1 | |
| 216.4 | 5,676.6 | 7.1 | -274.7 | -4,008.3 | -140.4 | -- | 8.5 |
Shareholding Pattern
View DetailsNews & Analysis
All News
About Orchid Pharma
Orchid Pharma Limited, a pharmaceutical company, engages in the development, manufacture, and marketing of active pharmaceutical ingredients, bulk actives, finished dosage formulations, and nutraceuticals in India. Its active pharmaceutical... ingredients product portfolio includes oral cephalosporins, injectable cephalosporins; human and veterinary products; and antibiotics, including betalactam, macrolide, fluoroquinolone, and imidazole. The company also exports its products to approximately 40 countries internationally. The company was formerly known as Orchid Chemicals & Pharmaceuticals Limited and changed its name to Orchid Pharma Limited in October 2015. Orchid Pharma Limited was incorporated in 1992 and is headquartered in Chennai, India. Orchid Pharma Limited operates as a subsidiary of Dhanuka Laboratories Limited. Read more
-
Incorporated
1992
-
Chairman
Ram Gopal Agarwal
-
Managing Director
Manish Dhanuka
-
Headquarters
Chengalpattu, Tamil Nadu
-
Website
Looking for more details about Orchid Pharma Ltd.’s IPO? Explore our IPO Details page.
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Quarterly Updates
Annual Reports
Announcements
View AnnouncementsIntimation Under Regulation 30
11-Apr-2026No News & Announcements are available.
FAQs for Orchid Pharma
What is the current share price of Orchid Pharma Ltd Today?
The share price of Orchid Pharma Ltd is ₹708.65 (NSE) and ₹707.80 (BSE) as of 12-May-2026 IST. Orchid Pharma Ltd has given a return of 19.55% in the last 3 years.
What is the current PB & PE ratio of Orchid Pharma Ltd?
The P/E ratio of Orchid Pharma Ltd is 190.27 times as on 12-May-2026, a 374 premium to its peers’ median range of 40.13 times.
The P/B ratio of Orchid Pharma Ltd is 2.85 times as on 12-May-2026, a 17 premium to its peers’ median range of 2.44 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
39.54
|
3.11
|
|
2024
|
57.52
|
4.53
|
|
2023
|
33.87
|
2.28
|
|
2022
|
0.00
|
1.79
|
|
2021
|
0.00
|
15.41
|
What is the 52 Week High and Low of Orchid Pharma Ltd?
The 52-week high and low of Orchid Pharma Ltd are Rs 899.00 and Rs 480.00 as of 12-May-2026.
What is the market cap of Orchid Pharma Ltd?
Orchid Pharma Ltd has a market capitalisation of ₹ 3,590 Cr as on 12-May-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Orchid Pharma Ltd?
Before investing in Orchid Pharma Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.